Fredun Pharmaceuticals Ltd.
BSE: 539730
₹2,324.50
₹-51.20
(-2.16%)
As on 03-Jun-2026IST
Market cap
₹1,281 Cr
Revenue (TTM)
₹639 Cr
P/E Ratio
39.3
P/B Ratio
4.5
Div. Yield
0 %
Quality Score
3/10
Growth Score
6/10
Valuation Score
4/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹37 Cr
-
ROE
14 %
-
ROCE
16.2 %
-
Industry P/E
45.28
-
EV/EBITDA
15.2
-
Debt to Equity
0.2
-
Book Value
₹513.6
-
EPS
₹73.5
-
Face value
10
-
Shares outstanding
5,512,690
10 Years Aggregate
CFO
₹-31.33 Cr
EBITDA
₹172.77 Cr
Net Profit
₹65.13 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fredun Pharma
| 47.3 | 4.2 | 49.1 | 226.4 | 39.8 | 40.7 | 65.4 |
|
BSE Healthcare
| 7.1 | 4.2 | 6.3 | 9.1 | 24.6 | 13.5 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Fredun Pharma
| 115.0 | -14.5 | -22.4 | 32.5 | 107.1 | 84.6 | -34.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Fredun Pharma
|
2,324.5 | 1,281.4 | 639.1 | 37.5 | 13.5 | 17.2 | 39.3 | 4.5 |
| 3,135.7 | 25,659.6 | 1,339.4 | 356.4 | 33.2 | 23.2 | 72 | 15.5 | |
| 424.8 | 16,247.6 | 2,268.6 | 150.1 | 10.6 | 5.4 | 90.7 | 4.2 | |
| 793.8 | 19,649.1 | 5,365.6 | 595.0 | 16.6 | 13.3 | 33 | 3.9 | |
| 934.5 | 16,761.1 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.8 | 1.8 | |
| 1,810.5 | 20,740.0 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.6 | |
| 167.0 | 22,211.7 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 1,272.0 | 21,040.8 | 1,284.3 | 134.4 | -- | 30.7 | 85.3 | 16.3 | |
| 438.1 | 17,704.9 | 3,738.7 | 316.7 | 12.5 | 7.5 | 55.9 | 3.7 | |
| 2,073.9 | 33,781.3 | 3,373.0 | 199.0 | 12.6 | 5.9 | 158.6 | 6.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Fredun Pharma
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
1987
-
Chairman
Daulat Medhora
-
Managing Director
Fredun Medhora
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Fredun Pharma
What is the current share price of Fredun Pharmaceuticals Ltd Today?
The share price of Fredun Pharmaceuticals Ltd is ₹2,324.50 (BSE) as of 03-Jun-2026 IST. Fredun Pharmaceuticals Ltd has given a return of 39.84% in the last 3 years.
What is the current PB & PE ratio of Fredun Pharmaceuticals Ltd?
The P/E ratio of Fredun Pharmaceuticals Ltd is 39.28 times as on 03-Jun-2026, a 13 discount to its peers’ median range of 45.28 times.
The P/B ratio of Fredun Pharmaceuticals Ltd is 4.53 times as on 03-Jun-2026, a 20 premium to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
15.99
|
2.23
|
|
2024
|
21.57
|
2.81
|
|
2023
|
32.60
|
4.00
|
|
2022
|
64.04
|
5.98
|
|
2021
|
91.79
|
4.29
|
What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?
The 52-week high and low of Fredun Pharmaceuticals Ltd are Rs 2,620.00 and Rs 705.00 as of 03-Jun-2026.
What is the market cap of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd has a market capitalisation of ₹ 1,281 Cr as on 03-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Fredun Pharmaceuticals Ltd?
Before investing in Fredun Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.